Development of a Bispecific Nanobody Targeting CD20 on B-Cell Lymphoma Cells and CD3 on T Cells

B-cell lymphoma is a group of malignant proliferative diseases originating from lymphoid tissue with different clinical manifestations and biological characteristics. It can occur in any part of the body, accounting for more than 80% of all lymphomas. The present study aimed to construct bispecific...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yanlong, Ao, Kexin, Bao, Fuxiang, Cheng, Yi, Hao, Yanxia, Zhang, Huimin, Fu, Shan, Xu, Jiaqi, Wu, Qiyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413575/
https://www.ncbi.nlm.nih.gov/pubmed/36016223
http://dx.doi.org/10.3390/vaccines10081335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413575/
https://www.ncbi.nlm.nih.gov/pubmed/36016223
http://dx.doi.org/10.3390/vaccines10081335

Ejemplares similares